Table 2.
Effect of Persea americana and glibenclamide on serum glucose levels on oral glucose tolerance test (OGTT) rats
| Treatment | Basal (mg/dL) | 30 min (mg/dL) | 60 min (mg/dL) | 120 min (mg/dL) |
|---|---|---|---|---|
| NC | 117.6 9.8 (9.8) | 113.6 (8.7) | 140.6 (5.3) (↑ 19.2%) | 117.0 (8.0) |
| PC (non treated DI) | 413.0 (88.1) | 427.0 (89.8) | 110.6 (24.3) | 0 |
| DI + 20 g/L P.a. | 216.6 (42.4) | 220.2 (44.0) | 275.6 (37.2) (↑ 20.1%) | 223.6 (40.3) |
| DI + 30 g/L P.a. | 192.0 (19.0) | 199.0 (19.0) | 262.2 (37.2) (↑ 24.1%) | 187.6 (11.1) |
| DI + 40 g/L P.a. | 189.0 (11.4) | 192.4 ± 11.8 | 246.6 ± 6.2 (↑ 22.0%) | 190.4 (9.0) |
| DI + GBM | 187.2 (7.0) | 189.0 (7.2) | 256.8 (32.9) (↑ 26.4%) | 187.2 (3.2) |
*All values are expressed as the mean (SD) (n = 5); diabetic control group (NC = Negative Control; PC = Positive Control, DI = diabetic induced, GBM = glibenclamide). Figures in parentheses indicate a percentage increase in the BGL of OGTT rats at different time intervals when compared to the basal blood glucose leve